Store Associate
About the job
- Be at least 16 years of age.
- Remain upright on the feet for sustained periods.
- Be able to lift and exert up to 35 pounds occasionally, up to 10 pounds frequently, and a negligible amount of force regularly to move objects, including overhead lifting.
- Have close visual acuity for tasks such as viewing a computer terminal, reading, and visual inspection involving small parts or details.
- Provide differentiated customer service by anticipating customer needs, demonstrating compassion and care in interactions, and identifying and resolving potential service issues.
- Greet customers warmly and in a friendly manner, maintain eye contact, and offer help locating additional items when needed.
- Accurately perform cashier duties, handling cash, checks, and credit card transactions while following company policies and procedures.
- Maintain the sales floor by restocking shelves, checking in vendors, updating pricing information, and completing inventory management tasks as directed by the store manager.
- Support opening and closing store activities when needed.
- Provide customer support to all departments, including photo and beauty, ensuring departments are fully stocked and operational while staying current with updated services and tools.
- Assist pharmacy personnel when needed, including working regular shifts in the pharmacy as part of growth and career development opportunities.
- Advocate for CVS services and loyalty programs that support customers' health.
- Previous experience in a retail or customer service setting.
- A high school diploma or equivalent.
About the company
CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.
Company Size
10,001+
Company Stage
IPO
Headquarters
Woonsocket, Rhode Island
Founded
1963
Get referred to CVS Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Second-quarter 2026 revenue reached $106.1 billion, and adjusted EPS rose to $2.58.
- CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 and cash flow above $11.5 billion.
- CVS launched GLP-1 support and $29 virtual visits, capturing weight-loss demand now.
What critics are saying
- 340B restrictions hit Caremark in 2026 and management expects pressure into 2027.
- Omnicare’s $949 million fraud case and $440 million settlement damage trust through 2028.
- Rite Aid transfer gains fade while Walgreens closures stop, squeezing prescription-share upside.
What makes CVS Health unique
- Caremark, Aetna, and CVS Pharmacy create unmatched insurance-to-retail integration.
- CVS opened pharmacy-only formats in Chicago in March 2026, sharpening prescription density.
- Teresa Heitsenrether joins the board November 2026, signaling stronger data-led operating discipline.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Company Equity
Wellness Program
Professional Development Budget
Paid Vacation
Paid Holidays
Company News
CVS Health has opened its first pharmacy-focused location in the Boston area, situated at 32 Warren Street in Roxbury. The company plans to launch nearly 20 such locations across the US in 2026 to increase access to pharmacy care. The new format features full-service pharmacies averaging 3,000 square feet, offering prescription medications, immunisations, and over-the-counter products. Customers can order additional items with free home delivery. The Roxbury site includes a medication disposal bin and safe needle collection point. These smaller pharmacies complement CVS's existing formats, including traditional stores, store-in-store locations in Target and Schnucks, and sites with MinuteClinic facilities. According to CVS Health's 2025 Rx Report, 80% of patients prefer face-to-face pharmacy care, whilst 48% would switch pharmacies if limited to digital-only options.
CVS Health faces an unquantified headwind from its 340B drug discount programme heading into 2027, management warned during its fiscal Q2 2026 earnings call in August. The company's shares have fallen 15.2% over the past three months, even as management raised its 2026 earnings outlook. The 340B business, which serves eligible healthcare organisations, is experiencing pressure as drugmakers limit programme coverage. Management expects this drag to continue affecting its pharmacy services business in 2027 but declined to quantify the potential impact. CVS's Health Services segment, which likely includes the 340B business, generated $190.4 billion in revenue during fiscal 2025. The company trades at 22.5 times trailing earnings, roughly level with the S&P 500's 22.4 multiple.
CVS Health's Omnicare division has completed its Chapter 11 bankruptcy liquidation after selling its business operations for $250 million. A Texas bankruptcy judge approved the wind-down plan following a $440 million settlement with the Justice Department over improper billing practices. Omnicare, which served nursing homes and long-term care facilities, filed for bankruptcy in September 2025 after facing a $949 million judgement for fraudulently dispensing drugs without valid prescriptions and billing federal healthcare programmes for false claims. The settlement requires CVS to pay $130 million upfront and cover the remaining $310 million if Omnicare fails to do so by March 2028. GenieRx Holdings, a joint partnership between Milrose Capital and Integro Asset Management, purchased Omnicare's operations. The sale is expected to close next month.
CVS Health shares have declined 2.1% over the past three months, prompting investors to consider whether now is an opportune time to buy. The healthcare giant, which operates approximately 9,000 retail pharmacy locations and serves more than 35 million people through its health insurance business, reported second-quarter revenue of $106 billion, up 7.3% year-over-year. Adjusted earnings per share rose 43% in the same period. The company offers a dividend yield of 2.8%, with its annual payout increasing from $2 in 2021 to $2.66 per share recently. Shares currently trade at $95, with one analyst setting a price target of $120. The stock's forward price-to-earnings ratio of 11 sits slightly above its five-year average of 10.
The health insurance industry may have recovered from high medical costs, with analysts predicting strong growth through 2030. Morningstar forecasts 16% annual earnings per share growth for major insurers, above the industry's typical low-double-digit target. Health insurers are improving profitability by raising rates to cover increased medical utilisation. UnitedHealth Group reported over $5 billion in second-quarter net income, with its medical care ratio falling to 86.7% from 89.4% year-over-year. The outlook also improved for pharmacy benefit management operations at companies like UnitedHealth, CVS Health, and Cigna. Despite increased regulatory scrutiny, the "big three" PBMs maintain strong competitive positions. Third-quarter earnings reports next month should provide further clarity on the industry's financial health.